Skip to main content

Table 3 Comparison between survivors and non-survivors

From: Pulmonary strongyloidiasis: assessment between manifestation and radiological findings in 16 severe strongyloidiasis cases

 

Non-survivors

Survivors

n = 5

(%)

n = 11

(%)

Male

1

(20)

6

(55)

Agea

66.8

(46–81)

79.8

(51–96)

Underlying conditions

 Serum albumin (g/dL)ab

2.0

(1.5–2.6)

2.4

(1.1–4.2)

 HTLV-1c

3

(75)

8

(80)

 Steroid user

2

(40)

3

(27)

 Anti-cancer drug

0

 

1

 

Underlying disease

 Adult T-cell lymphoma/leukemia

1

(20)

4

(27)

 Type 2 diabetes mellitus

2

(40)

1

(9)

Cases with pulmonary complication

5

(100)

10

(91)

 Acute respiratory distress syndrome

4

 

4

 

 Pulmonary alveolar hemorrhage

1

 

2

 

Other complication

 Systemic infection

5

(100)

5

(45)

  Sepsis

4

 

4

 

Meningitis

3

 

2

 

 Ileus

1

(20)

3

(27)

  1. Abbreviations: HTLV-1 = human T-cell leukemia virus type 1, amean (range) was used for these values, btotal 13 cases (3 non-survivors and 10 survivors) were tested serum albumin, ctotal 14 cases (4 non-survivors and 10 survivors) were tested HTLV-1
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us